Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SSX4 anticorps (AA 63-91)

SSX4 Reactivité: Humain WB Hôte: Lapin Polyclonal RB32991 unconjugated
N° du produit ABIN657137
  • Antigène Voir toutes SSX4 Anticorps
    SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))
    Épitope
    • 12
    • 12
    • 7
    • 7
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 63-91
    Reactivité
    • 43
    • 1
    • 1
    Humain
    Hôte
    • 39
    • 4
    Lapin
    Clonalité
    • 41
    • 2
    Polyclonal
    Conjugué
    • 16
    • 5
    • 4
    • 4
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SSX4 est non-conjugé
    Application
    • 35
    • 28
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This SSX4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 63-91 amino acids from the Central region of human SSX4.
    Clone
    RB32991
    Isotype
    Ig Fraction
    Top Product
    Discover our top product SSX4 Anticorps primaire
  • Indications d'application
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Date de péremption
    6 months
  • Antigène
    SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))
    Autre désignation
    SSX4 (SSX4 Produits)
    Synonymes
    anticorps CT5.4, anticorps SSX family member 4, anticorps SSX4
    Sujet
    The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. Chromosome Xp11 contains a segmental duplication resulting in two identical copies of synovial sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail orientation. This gene, SSX4B, represents the more centromeric copy. Two transcript variants encoding distinct isoforms have been identified for this gene.
    Poids moléculaire
    21858
    NCBI Accession
    NP_001030004, NP_001035702, NP_005627, NP_783856
    UniProt
    O60224
Vous êtes ici:
Support technique